Betta Pharmaceuticals Co., Ltd.
- Country
- 🇨🇳China
- Ownership
- Joint Venture, Public, Subsidiary
- Established
- 2003-01-07
- Employees
- 1.9K
- Market Cap
- -
- Website
- https://www.bettapharma.com
High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases
- Conditions
- Interventions
- First Posted Date
- 2016-04-01
- Last Posted Date
- 2019-02-19
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT02726568
- Locations
- 🇨🇳
West China Hospital, Chengdu, Sichuan, China
Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients
- Conditions
- Interventions
- First Posted Date
- 2015-10-12
- Last Posted Date
- 2017-07-13
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT02574091
- Locations
- 🇳🇿
Christchurch Clinical Studies Trust, Christchurch, New Zealand
Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia
- First Posted Date
- 2015-09-09
- Last Posted Date
- 2015-09-09
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 44
- Registration Number
- NCT02544789
- Locations
- 🇨🇳
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
🇨🇳Department of Pediatrics, Peking University People's Hospital, Beijing, China
🇨🇳The First Hospital of China Medical University, Shenyang, China
Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy
- First Posted Date
- 2015-07-01
- Last Posted Date
- 2015-07-01
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 128
- Registration Number
- NCT02486354
- Locations
- 🇨🇳
307 Hospital of PLA, Beijing, Beijing, China
🇨🇳Jiangsu Cancer Hospital, Nanjing, Jiangsu, China
🇨🇳Third Affiliated Hospital, Third Military Medical University, Chongqing, Chongqing, China
Safety and Pharmacokinetics of BPI-9016M in Patients With Advanced Solid Tumors
- First Posted Date
- 2015-06-23
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT02478866
- Locations
- 🇨🇳
Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
🇨🇳Peking Union College Hospital, Beijing, Beijing, China
Icotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA NSCLC With EGFR-mutation
- First Posted Date
- 2015-05-19
- Last Posted Date
- 2021-07-20
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 320
- Registration Number
- NCT02448797
- Locations
- 🇨🇳
307 Hospital of PLA, Beijing, Beijing, China
🇨🇳Fujian Provincal Cancer Hospital, Fuzhou, Fujian, China
🇨🇳The First Affiliated Hospital Of Guangzhou Medical Collage, Guangzhou, Guangdong, China
High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation
- First Posted Date
- 2015-03-31
- Last Posted Date
- 2017-07-28
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT02404675
- Locations
- 🇨🇳
Beijing Chest Hospital, Capital Medical University, Beijing, China
A Phase II Study of Icotinib in Treating Patients With Advanced Nasopharyngeal Carcinoma
- First Posted Date
- 2014-12-31
- Last Posted Date
- 2014-12-31
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 66
- Registration Number
- NCT02328261
Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer
- First Posted Date
- 2014-10-30
- Last Posted Date
- 2015-05-22
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT02278458
- Locations
- 🇨🇳
Cancer Hospital of Harbin Medical University, Harbin, Heilongjiang, China
🇨🇳Bethune First Hospital of Jilin University, Changchun, Jilin, China
🇨🇳First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China
Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2014-08-13
- Last Posted Date
- 2014-08-13
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT02215356
- Locations
- 🇨🇳
Beijing Union Medical College Hospital, Beijing, Beijing, China
🇨🇳Dongguan City People's Hospital, Dongguan, Guangdong, China
🇨🇳Guangxi Zhuang Autonomous Region People's Hospital, Nanning, Guangxi, China